Because of the relationship between bodyweight and the risk of diabetes, researchers sought to examine the long-term effects of a selective serotonin 2C receptor agonist and appetite-suppressant drug which...
In a recent study, researchers sought to evaluate the impact of treatment with a glucagon-like peptide 1 receptor agonist on rates of cardiovascular events in patients with type 2 diabetes and...
As treatment of type 1 diabetes continues to improve, more patients with the condition are expected to survive to adulthood, according to the researchers. For this reason, they sought to examine the...
Javier Morales, MD, offered a review of glucagon-like peptide-1 receptor agonists and how they fit into the management of patients with type 2 diabetes.
It may be time to ditch the stepwise approach and embrace combination therapy in treating type 2 diabetes, said James R. Gavin III, MD, PhD, at CRS 2018.
Previous evidence has suggested a complex relationship between OSA and diabetes, but to date, no population-based study has evaluated the potential bidirectional association between the 2 disorders.
Consultant360 spoke with Dr Jeffrey Scherrer from St Louis University School of Medicine about his new study, which explored the effect modification of obesity on the association between posttraumatic...
Although excess mortality risk is common in patients with diabetes, it is less well understood how the presence of common comorbidities affects this risk.
